According to Dipan Mehta the correction seen in pharma stocks on back of the geo-political issues in Ukraine is an opportunity to buy into because going forward too there is growth coming in for pharma cos from US and developed East-European markets
Calling the current optimism in the market as a hope rally driven by FIIs, UR Bhat says India has been spared the cold shouldering of the global community so far.